Schizophrenia Clinical Trial
Official title:
Animal-Assisted Therapy in Middle-aged and Older Patients With Schizophrenia
Animal-assisted therapy (AAT) can be helpful to improve the psychiatric, emotional,
physical,and social status in patients with physical and mental illness and the elderly.
The study aims to investigate the effects of AAT program in middle-aged and older patients
with schizophrenia. The investigators will recruit 40 patients with schizophrenia in
psychiatric ward randomised into AAT group and control group. AAT group will complete the
12-week program. This study contains two assessment sessions before and after intervention,
including PANSS, ACIS, MoCA-T, CHI, DASS‐21, CST, TUG and 5MWT.
Animal-assisted therapy (AAT) can be helpful to improve the outcomes of psychiatric and
emotional symptoms, physical activeness, social skills, well-beings in patients with physical
and mental illness and the elderly.
The study aims to assess the applications and outcomes of psychiatric symptoms, social
skills, cognitive function, well-beings, emotional status and physical fitness of AAT program
applied to middle-aged and older patients with chronic schizophrenia.
The investigators will recruit 40 patients with chronic schizophrenia who were admitted to
day care ward and rehabilitation ward, and conduct a randomized, controlled study. 40
patients will be stratified by the ward into AAT group and control group. AAT group will
complete the 12-week program. This study contains two assessment sessions completed within
one week before and after 12-week program. Subjects will be evaluated by the PANSS, ACIS,
MoCA-T, CHI, DASS‐21, CST, TUG and 5MWT in both sessions. Statistical analysis is examined
using paired t-test to see whether there is a significant difference (based on p‐value)
between the scores of two assessment sessions in the AAT and control group, and using
independent t-test to see whether there is a significant difference in the change scores of
two assessment sessions between the 2 groups.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |